Skip to main content
Leslie Harrold, MD, Rheumatology, Worcester, MA

Leslie Harrold MD

Crystal Related, Rheumatoid Arthritis & Related


Associate Professor, Medicine, University Massachusetts Medical School

Join to View Full Profile
  • 55 Lake Ave NDepartment Of RheumatologyWorcester, MA 01655

  • Phone+1 508-334-5224

Dr. Harrold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Rheumatology, 1995 - 1998
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1992 - 1995
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1992

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2020
  • CT State Medical License
    CT State Medical License Active through 2013

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Oxford University Press Has Registered This DOI Pre-Publication  
    Leslie Harrold, MD, Oxford University Press

Press Mentions

  • Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases
    Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
  • Treatment Failing Majority of RA Patients
    Treatment Failing Majority of RA PatientsNovember 27th, 2019
  • Bristol-Myers Squibb Underscores Precision-Focused Immunology Leadership with New Data on ORENCIA® (Abatacept) in Early RA, ACPA-Positive Patients Presented at 2019 ACR/ARP Annual Meeting1
    Bristol-Myers Squibb Underscores Precision-Focused Immunology Leadership with New Data on ORENCIA® (Abatacept) in Early RA, ACPA-Positive Patients Presented at 2019 ACR/ARP Annual Meeting1November 7th, 2019
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: